• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Quantitative proteomic profiling reveals that diverse metabolic pathways are influenced by melatonin in an in vivo model of ovarian carcinoma 09 September 2016
Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis 07 September 2016
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer 07 September 2016
Association of shift-work, daytime napping, and nighttime sleep with cancer incidence and cancer-caused mortality in Dongfeng-tongji cohort study 02 September 2016
Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactions 01 September 2016
Vitamin D and urological cancers 26 August 2016
The profile of melatonin receptors gene expression and genes associated with their activity in colorectal cancer: a preliminary report 26 August 2016
Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan 26 August 2016
Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells 25 August 2016
1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition 24 August 2016
Display # 

Page 112 of 172

  • Start
  • Prev
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
  • Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
  • Melatonin in cancer management: progress and promise
  • Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
  • Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
  • Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
  • The impact of vitamin D on cancer: A mini review
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
  • Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
  • Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
  • Melatonin: an endogenous miraculous indolamine, fights against cancer progression
  • Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer